1. Division of Surveillance and Analysis, Office of Safety I; Pharmaceuticals and Medical Devices Agency; Tokyo; Japan
2. Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research; U.S. Food and Drug Administration, Silver Spring, MD 20993, USA